Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06574048
PHASE1/PHASE2

Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy

Sponsor: University of Nebraska

View on ClinicalTrials.gov

Summary

Hyperbaric Oxygen Therapy (HBO) is routine treatment of carbon monoxide (CO) poisoning to prevent delayed neurological sequelae. This study looking to see if neurologic outcomes are improved with the addition of dexamethasone. CO poisoning can initiate a free radical mediated process that can instigate a demyelinating process resulting in long term neurological sequelae in some, but not all patients. In other demyelinating disorders, steroids are a part of first line treatment. HBO is already used for acute CO poisoning, so this pilot study will try to ascertain if the addition of steroids in concert with each hyperbaric oxygen session will yield improved outcomes.

Official title: Trial of Dexamethasone vs Placebo as an Adjunctive Therapy to Hyperbaric Oxygen Treatment HBO in Patients With Acute Carbon Monoxide Poisoning

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-01

Completion Date

2028-01

Last Updated

2025-10-14

Healthy Volunteers

No

Interventions

DRUG

saline placebo

IV saline bolus

DRUG

Dexamethasone

10mg IV Dexamethasone

Locations (1)

Nebraska Medicine, Hyperbaric Medicine Program, Clarkson Tower

Omaha, Nebraska, United States